LILRB4-targeting Antibody–Drug Conjugates for the Treatment of Acute Myeloid Leukemia

Written By Lara Wilson

Anami Y. et al. 2020. Molecular Cancer Therapeutics. 19(11):2330-2339

Lara Wilson
Previous

Preclinical characterization of a novel therapeutic antibody targeting LILRB2
Next

Antagonist antibodies targeting LAIR1 promote inflammatory phenotype in myeloid cells and activate lymphocytes